Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Revenue projections:

DVA is projected to experience a revenue decline compared to last year, a development that often leads to investor caution. The drop could negatively impact the company's bottom line, as lower revenues typically signal reduced profitability, prompting more conservative investment strategies.

Financial Ratios:

currentRatio	1.46700
forwardPE	10.42360
debtToEquity	1241.98600
earningsGrowth	0.55800
revenueGrowth	0.05200
grossMargins	0.32364
operatingMargins	0.16061
trailingEps	11.80000
forwardEps	17.14283

DVA's current ratio, being 1.467, means the company is well-positioned to meet its short-term debt obligations. This reflects DVA's strong liquidity, as its cash reserves and current assets provide more than enough coverage for its immediate liabilities.
DaVita Inc.'s Forward PE is positioned well, reflecting a favorable balance between stock price and earnings. The stock isn't overpriced, offering room for growth and making it a potentially rewarding investment as its value has room to rise further.
DVA's high debt-to-equity ratio points to a heavily leveraged company. With more debt than equity, DVA may face increased financial risk, especially if its earnings or cash flow come under pressure.
DaVita Inc.'s forward EPS surpasses its trailing EPS, indicating that the company is expected to be more profitable in the current financial year. This reflects growing confidence in DaVita Inc.'s earnings potential, suggesting stronger financial performance compared to the previous year.

Price projections:

DVA's price has consistently hovered around the lower end of analysts' projections. This pattern may reflect concerns regarding the company's ability to achieve its anticipated growth.

Insider Transactions:

DaVita Inc. experienced 11 selling transactions, with market price of 179.82272546941584.The period under consideration saw no sell transactions.The trend of more buys than sells at DVA's current price levels suggests a possible bullish sentiment. This could indicate that investors are expecting a favorable outlook for the stock, prompting more buying activity.

Recommendation changes over time:

The recent buy bias for DaVita Inc. from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see DaVita Inc. as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.